SarCNU in Treating Patients With Recurrent Malignant Glioma

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 10, 2002

Primary Completion Date

April 15, 2003

Study Completion Date

September 22, 2008

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

SarCNU

Trial Locations (5)

T2N 4N2

Tom Baker Cancer Center - Calgary, Calgary

K1H 1C4

Ottawa Regional Cancer Centre, Ottawa

M4N 3M5

Toronto Sunnybrook Regional Cancer Centre, Toronto

M5G 2C4

Toronto General Hospital, Toronto

H2W 1S6

McGill University, Montreal

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK